Feb 12, 2018 21:05 pm UTC| Business
BOULDER, Colo., Feb. 12, 2018 -- Gaia, Inc. (NASDAQ:GAIA), a conscious media company, will conduct a conference call on Monday, February 26, 2018 at 4:30 p.m. Eastern time (2:30 p.m. Mountain time) to discuss its...
Affimed Announces Proposed Public Offering of Common Stock
Feb 12, 2018 21:04 pm UTC| Business
Heidelberg, Germany February 12, 2018 - Affimed N.V. (Nasdaq: AFMD), a clinical stage biopharmaceutical company focused on discovering and developing highly targeted cancer immunotherapies, today announced that it has...
CyberPatriot Holds Proof of Concept for New CyberGenerations Program
Feb 12, 2018 21:02 pm UTC| Business
Arlington, Va., Feb. 12, 2018 -- The Air Force Association’s (AFA) CyberPatriot program announced today it has held a proof of concept for its new CyberGenerations program, designed to promote cyber safety for mature...
Giga-tronics Reports Third Quarter FY 2018 Results
Feb 12, 2018 21:02 pm UTC| Business
DUBLIN, Calif., Feb. 12, 2018 -- Giga-tronics Incorporated (OTCQB:GIGA) (the “Company”) reported today its financial results for the third fiscal quarter and nine-month period ended December 30, 2017. For the third...
Pacific Biosciences of California, Inc. Announces Proposed Public Offering of Common Stock
Feb 12, 2018 21:01 pm UTC| Business
MENLO PARK, Calif., Feb. 12, 2018 -- Pacific Biosciences of California, Inc. (NASDAQ:PACB) today announced that it intends to offer and sell shares of its common stock in an underwritten public offering. Pacific...
Adverum Biotechnologies Announces Closing of $69 Million Public Offering
Feb 12, 2018 21:01 pm UTC| Business
MENLO PARK, Calif., Feb. 12, 2018 -- Adverum Biotechnologies, Inc. (Nasdaq:ADVM), a clinical-stage gene therapy company targeting unmet medical needs in serious rare and ocular diseases, today announced the closing of...
NEA Partner Ali Behbahani, M.D. Joins Genocea Biosciences’ Board of Directors
Feb 12, 2018 21:01 pm UTC| Business
CAMBRIDGE, Mass., Feb. 12, 2018 -- Genocea Biosciences, Inc. (NASDAQ:GNCA), a biopharmaceutical company developing neoantigen cancer vaccines, today announced that Ali Behbahani, M.D., a partner in the healthcare group...